THE GORDON WILSON LECTURE: CANCER GENE VARIANT (RE)CLASSIFICATION: FROM TRUTHINESS TO TRUTH

Overview

Journal Trans Am Clin Climatol Assoc

Specialty Rehabilitation Medicine

Date 2018 Sep 1

PMID 30166705

Authors

Theodora Ross

Affiliations

Soon will be listed here.

Abstract

The new genetics, defined as that which followed the completion of the human genome project and includes development of rapid and cheaper next-generation sequencing (NGS), is impacting our medical world in several ways (1). As is the case in any new area of medicine, the field is infused with "truthiness," where instead, what is needed for good patient care and scientific rigor is an effort to close in on the truth. Today, I'll discuss how variation in the human genome is being evaluated and re-evaluated as we sequence more and more of our patients' genes.

References

Rebbeck T, Friebel T, Lynch H, Neuhausen S, van t Veer L, Garber J . Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004; 22(6):1055-62. DOI: 10.1200/JCO.2004.04.188. View

Bartsch O, Schmidt S, Richter M, Morlot S, Seemanova E, Wiebe G . DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet. 2005; 117(5):485-93. DOI: 10.1007/s00439-005-1331-y. View

Garber J . THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS. Trans Am Clin Climatol Assoc. 2017; 127:127-139. PMC: 5216520. View

Rebbeck T, Kauff N, Domchek S . Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009; 101(2):80-7. PMC: 2639318. DOI: 10.1093/jnci/djn442. View

Bell C, Dinwiddie D, Miller N, Hateley S, Ganusova E, Mudge J . Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011; 3(65):65ra4. PMC: 3740116. DOI: 10.1126/scitranslmed.3001756. View

Mgbemena V, Signer R, Wijayatunge R, Laxson T, Morrison S, Ross T . Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function. Cell Rep. 2017; 18(4):947-960. PMC: 5267932. DOI: 10.1016/j.celrep.2016.12.075. View

Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M . The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997; 336(20):1401-8. DOI: 10.1056/NEJM199705153362001. View

Mai P, Garceau A, Graubard B, Dunn M, McNeel T, Gonsalves L . Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst. 2011; 103(10):788-97. PMC: 3096799. DOI: 10.1093/jnci/djr114. View

Cantor D . The frustrations of families: Henry Lynch, heredity, and cancer control, 1962-1975. Med Hist. 2006; 50(3):279-302. PMC: 1483189. View

10.

Roelfsema J, Peters D . Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med. 2007; 9(23):1-16. DOI: 10.1017/S1462399407000415. View

11.

Sun S, Yang F, Tan G, Costanzo M, Oughtred R, Hirschman J . An extended set of yeast-based functional assays accurately identifies human disease mutations. Genome Res. 2016; 26(5):670-80. PMC: 4864455. DOI: 10.1101/gr.192526.115. View

12.

Benartzi S, Thaler R . Economics. Behavioral economics and the retirement savings crisis. Science. 2013; 339(6124):1152-3. DOI: 10.1126/science.1231320. View

13.

Lancaster J, Wooster R, Mangion J, Phelan C, Cochran C, Gumbs C . BRCA2 mutations in primary breast and ovarian cancers. Nat Genet. 1996; 13(2):238-40. DOI: 10.1038/ng0696-238. View

14.

Kamihara J, Rana H, Garber J . Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat. 2014; 35(6):654-62. DOI: 10.1002/humu.22559. View

15.

Desai S, Jena A . Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial. BMJ. 2016; 355:i6357. PMC: 5156611. DOI: 10.1136/bmj.i6357. View

16.

Hampel H, de la Chapelle A . How do we approach the goal of identifying everybody with Lynch syndrome?. Fam Cancer. 2013; 12(2):313-7. PMC: 4337020. DOI: 10.1007/s10689-013-9611-5. View

17.

Foley S, Rios J, Mgbemena V, Robinson L, Hampel H, Toland A . Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic. EBioMedicine. 2015; 2(1):74-81. PMC: 4444225. DOI: 10.1016/j.ebiom.2014.12.003. View

18.

Drohan B, Roche C, Cusack Jr J, Hughes K . Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012; 19(6):1732-7. DOI: 10.1245/s10434-012-2257-y. View

19.

Sanchez-Ramirez C, Flores-Martinez S, Garcia-Zapien A, Montero-Cruz S, Larrosa-Haro A, Sanchez-Corona J . Screening of R122H and N29I mutations in the PRSS1 gene and N34S mutation in the SPINK1 gene in Mexican pediatric patients with acute and recurrent pancreatitis. Pancreas. 2012; 41(5):707-11. DOI: 10.1097/MPA.0b013e31823cd873. View

20.

Desai A, Jere A . Next-generation sequencing: ready for the clinics?. Clin Genet. 2012; 81(6):503-10. DOI: 10.1111/j.1399-0004.2012.01865.x. View